Fintel reports that on July 18, 2025, Maxim Group initiated coverage of Akari Therapeutics, Plc - Depositary Receipt () ...

Maxim analyst Jason McCarthy initiated coverage of Akari Therapeutics (AKTX) with a Buy rating and $5 price target Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! ...

Authorities in Northport and Tuscaloosa County say a man has been arrested on charges of possessing a ‘Glock switch’ under a ...

It ended nearly a year-long stint with Choco Mucho, highlighted by her first PVL silver medal and a top four league finish.

Akari crawled back from eight points down in the third set en route to a 25-23, 25-18, 25-23 win against Capital1 in the 2025 ...

Multiple insiders secured a larger position in Akari Therapeutics, Plc ( NASDAQ:AKTX ) shares over the last 12 ...

AKARI restored its winning form against Capital1, 25-23, 25-18, 26-24, in the 2025 PVL on Tour on Tuesday at the Playtime ...

Well Go USA has released a trailer, poster and images for Baby Assassins 3, the third instalment in the action comedy ...

"Worst case scenario, you two can just be my decoys." "Can I kill her?" ⚔ Well Go USA has revealed an official trailer for ...

Gretchen Soltones said Akari’s immediate concern heading into the coming PVL tournament is getting much-needed chemistry ...

Akari snapped a two-game skid and gave new coach Tina Salak a winning debut, surviving ZUS Coffee, 26-24, 25-21, 17-25, 17-25 ...

--Akari Therapeutics, Plc, an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates for the treatment of cancer, today announced it recently participated ...